Oppenheimer Initiates Coverage On Gossamer Bio With Outperform Rating, Announces Price Target of $9
Oppenheimer Initiates Coverage On Gossamer Bio With Outperform Rating, Announces Price Target of $9
Oppenheimer分析師Andreas Argyrides開始覆蓋Gossamer Bio,並給予超越評級,宣佈價格目標爲9美元。
Oppenheimer analyst Andreas Argyrides initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Outperform rating and announces Price Target of $9.
Oppenheimer分析師Andreas Argyrides以買入評級開始了對Gossamer Bio(納斯達克股票代碼:GOSS)的覆蓋,並宣佈了9美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。